{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:26:41Z","timestamp":1787430401144,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbadis.2026.168346","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:00:08Z","timestamp":1784239208000},"page":"168346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Activation of OSMR-STAT3 signaling by AID promotes immune microenvironment remodeling in hepatocellular carcinoma"],"prefix":"10.1016","volume":"1872","author":[{"given":"Zhuangwei","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168346_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular carcinoma: new developments","volume":"27","author":"Ganesan","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbadis.2026.168346_bb0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/CM9.0000000000002641","article-title":"Precision diagnosis of hepatocellular carcinoma","volume":"136","author":"Wang","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbadis.2026.168346_bb0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.bbadis.2026.168346_bb0020","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168346_bb0025","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070961","article-title":"PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2024.12.002","article-title":"Targeting immune evasion in hepatocellular carcinoma-initiating cells","volume":"46","author":"Sirera","year":"2025","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168346_bb0040","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","article-title":"Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy","volume":"22","author":"Seyhan","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108298","article-title":"PPARgamma signaling in hepatocarcinogenesis: mechanistic insights for cellular reprogramming and therapeutic implications","volume":"240","author":"Ishtiaq","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2026.168346_bb0050","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","article-title":"FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity","volume":"82","author":"Yang","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/Jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2026.168346_bb0060","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jamaoncol.2024.4085","article-title":"Complete response to locoregional therapy plus immunotherapy for hepatocellular carcinoma","volume":"10","author":"Chiang","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2468-1253(24)00247-4","article-title":"Combination locoregional and systemic therapies in hepatocellular carcinoma","volume":"10","author":"Zhong","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1158\/0008-5472.CAN-23-1796","article-title":"Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy","volume":"84","author":"Mu","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168346_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009993","article-title":"Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway","volume":"13","author":"Wei","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2026.168346_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2026.168346_bb0085","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/gutjnl-2022-328364","article-title":"Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma","volume":"72","author":"Xiong","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2026.168346_bb0090","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.4049\/jimmunol.2101193","article-title":"Activation-induced cytidine deaminase impacts the primary antibody repertoire in naive mice","volume":"208","author":"Bao","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/dna.2019.5119","article-title":"Activation-induced cytidine deaminase expression facilitates the malignant phenotype and epithelial-to-mesenchymal transition in clear cell renal cell carcinoma","volume":"39","author":"Che","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221528","article-title":"The off-target effects of AID in carcinogenesis","volume":"14","author":"Jiao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0105","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-21-0483","article-title":"Oncostatin M receptor-targeted antibodies suppress STAT3 signaling and inhibit ovarian cancer growth","volume":"81","author":"Geethadevi","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168346_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41698-024-00593-y","article-title":"Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer","volume":"8","author":"Geethadevi","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0115","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/s41467-021-27607-8","article-title":"Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168346_bb0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41590-025-02149-z","article-title":"The IL-22-oncostatin M axis promotes intestinal inflammation and tumorigenesis","volume":"26","author":"Cineus","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215880","article-title":"Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity","volume":"547","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2026.168346_bb0130","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168346_bb0135","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/1878-0261.13263","article-title":"Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis","volume":"16","author":"Li","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41419-024-06456-5","article-title":"Dietary long-chain fatty acids promote colitis by regulating palmitoylation of STAT3 through CD36-mediated endocytosis","volume":"15","author":"Wei","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168346_bb0145","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100207R","article-title":"Protein tyrosine phosphatome metabolic screen identifies TC-PTP as a positive regulator of cancer cell bioenergetics and mitochondrial dynamics","volume":"35","author":"Vinette","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2026.168346_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2026.168346_bb0155","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of STAT3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168346_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101073","article-title":"Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors","volume":"25","author":"Lee","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41419-025-07558-4","article-title":"CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R\/JAK2\/STAT3 positive feedback loop","volume":"16","author":"Feng","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168346_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400348","article-title":"JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review","volume":"15","author":"Atschekzei","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168346_bb0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into IL-6\/JAK\/STAT3 signaling in the tumor microenvironment: implications for cancer therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbadis.2026.168346_bb0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41419-024-06895-0","article-title":"Elucidating the role of S100A10 in CD8(+) T cell exhaustion and HCC immune escape via the cPLA2 and 5-LOX axis","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:20:41Z","timestamp":1787430041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0925443926002097"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168346","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of OSMR-STAT3 signaling by AID promotes immune microenvironment remodeling in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168346"}}